R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18–45 years: an open-label, partially blinded, phase 1–2a controlled human malaria infection study

Venkatraman N., Silman D., Bellamy D., Stockdale L., Bowyer G., Edwards NJ., Griffiths O., Lopez FR., Powlson J., Mair C., Folegatti PM., Datoo MS., Morter R., Minassian AM., Poulton I., Collins KA., Brod F., Angell-Manning P., Berrie E., Brendish N., Glenn G., Fries L., Baum J., Blagborough AM., Roberts R., Lawrie AM., Angus B., Lewis DJM., Faust SN., Ewer KJ., Hill AVS.

DOI

10.1016/s2666-5247(24)00083-1

Type

Journal article

Publisher

Elsevier BV

Publication Date

2025-03-01T00:00:00+00:00

Volume

6

Pages

100867 - 100867

Total pages

0

Permalink More information Close